Koh · In vivo (Athens, Greece) 2013 · in vitro comparative cell culture study · n=?

Re-evaluation of anti-inflammatory potential of eugenol in IL-1β-stimulated gingival fibroblast and pulp cells.

Cited 24 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

In vitro cell culture bench research without human subjects

PubMed 23422489 · record verified 2026-08-28

What was done

Researchers investigated the effects of eugenol (5–500 μM) on interleukin-8 (IL-8) production in human oral cells and cell lines stimulated with interleukin-1β (IL-1β, 5 ng/ml) or lipopolysaccharide. Tested cells included human gingival fibroblasts (HGF), periodontal ligament fibroblasts (HPLF), human pulp cells (HPC), skin keratinocytes (HaCat), and oral squamous cell carcinoma cell lines (HSC-2, HSC-4). Viable cell numbers were determined by hemocytometer counting after trypsinization, and IL-8 release into culture media was measured via enzyme-linked immunosorbent assay (ELISA) with and without fetal bovine serum.

What was found

IL-1β induced two orders of magnitude higher IL-8 production than baseline. Stimulated HGF and HPLF produced approximately 200–300 ng/ml of IL-8, HPCs produced approximately 40–50 ng/ml, and HaCat, HSC-2, and HSC-4 cells produced less than 15 ng/ml. Omitting fetal bovine serum reduced IL-8 production by approximately 90%. Eugenol (5–500 μM) significantly stimulated IL-8 production in HGF cells. In HPCs, eugenol exhibited bimodal effects, slightly stimulating IL-8 at 5 μM and significantly inhibiting it at 500 μM, with or without serum. Similar patterns were observed with lipopolysaccharide stimulation.

Why it matters

Eugenol demonstrated anti-inflammatory suppression of IL-8 only in pulp cells at high concentrations, while promoting pro-inflammatory IL-8 release in gingival fibroblasts. This suggests cell-type-dependent actions and a narrow therapeutic range in dental applications.

Limits

The study is entirely in vitro, which does not account for complex tissue environments, systemic clearance, or in vivo immune responses. Exact replicate numbers, cytotoxicity metrics for specific concentrations, and variance or confidence intervals were not reported in the abstract.

Cited by